How much funding has EBAMED raised?

EBAMED has raised $20.0M in total funding, most recently a Series A round.

Who are EBAMED's investors?

EBAMED's investors include Venture Kick, Panakès Partners, European Innovation Council Fund, Fongit Seed Invest.

Where is EBAMED headquartered?

EBAMED is headquartered in Geneva.

What industry is EBAMED in?

EBAMED operates in Biotech, Medical Devices.

EBAMED

Geneva · Founded 2018 · $20.0M raised

Biotech

Medical Devices

Headquarters: Geneva
Founded: 2018
Business Model: B2B
Website: eba-med.com

Total Funding: $20.0M
Last Round: $15.7M Series AJun 2023
Rounds: 5

About

EBAMed is a Geneva, Switzerland-based medical device company developing innovative image-guidance and proton-therapy solutions for the non-invasive, painless treatment of heart arrhythmias via external beam ablation. Building on preclinical research from its co-founder team on using protons for arrhythmia treatment, EBAMed aims to make proton therapy a practical, non-invasive alternative to current catheter-based cardiac ablation technologies, enabling treatment at an earlier stage of disease.

Summary

EBAMED is a Biotech company based in Geneva, founded in 2018. It has raised $20.0M in total across 5 rounds, most recently a $15.7M Series A round in Jun 2023. Investors include Venture Kick, Panakès Partners and European Innovation Council Fund.